Page 1

Vacunación antineumocócica UGC Medicina Interna y Especialidades Médicas Hospital Comarcal de la Axarquía Área de Gestión Sanitaria Este de Málaga-Axarquía Dr. Carlos Rueda 25.04.2012


Age and Comorbidities Are Risk Factors for CAPa Selected Spanish Studies 2008-20091,2 – – – – – – – – – – –

Age ≥65 years Regular cigarette smoking Chronic bronchitis (COPD) Heart disease Hypertension Diabetes mellitus Alcohol consumption Immunosuppression Asthma Chronic liver disease Malignancies

a

All-cause CAP, based on predefined criteria for registration as acute lower respiratory tract infection, for which antibiotics were prescribed, associated with new focal signs on examination of the chest and a radiographic infiltrate indicative of pneumonia, which was required for all suspected cases 1 1. Almirall J, et al. Eur Respir J. 2008;31(6):1274-1284. 2. Martinez D, et al. Rev Esp Quimioter. 2009;22(1):4-9.


OPA POSTSERIE PRIMARIA

Niveles AC (GMCs) 1ª, prerrefuerzo y post refuerzo


Estudios pendientes •Pacientes de 6-49 años •VIH •Drepanocitosis. •Duración del efecto y necesidad de revacunación


Conclusiones


Vacunación Antineumococica  

Sesión Clínica. Dr. Carlos Rueda. Unidad Neumología. UGC Medicina Interna y Especialidades Médicas. AGS Este de Málaga-Axarquia. Abril 2012